Human papilloma virus type and recurrence rate after surgical clearance of anal condylomata acuminata

Sexually Transmitted Diseases

Volumn 36, Issue 9, 2009, Pages 536-540

  Dambrogio, Aris ^a   Yerly, Stéphane ^b   Sahli, Roland ^b   Bouzourene, Hanifa ^b   Demartines, Nicolas ^b   Cotton, Michael ^b   Givel, Jean Claude ^b  

^a Hôpital du Jura Bernois SA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BISEXUALITY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MONTE CARLO METHOD; POLYMERASE CHAIN REACTION; RECURRENCE RISK; RECURRENT INFECTION; SEXUAL BEHAVIOR; TREATMENT OUTCOME; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

ADULT; ANAL CANAL; CONDYLOMATA ACUMINATA; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; MONTE CARLO METHOD; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRES; RECURRENCE; SWITZERLAND;

EID: 70349311753     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181a866a3     Document Type: Article

References (36)

1. Consten EC, Slors FJ, Noten HJ, et al. Anorectal surgery in human immunodeficiency virus-infected patients: Clinical outcome in relation to immune status. Dis Colon Rectum 1995; 38:1169-1175.
2. Trottier H, Franco El. The epidemiology of genital human papilloma virus. Vaccine 2006; 24:S1-S15.
3. Dev D, Lo Y, Ho GY, et al. Incidence of and risk factors for genital human papillomavirus infection in women drug users. J Acquir Immun Defic Syndr 2006; 41:527-529.
4. Chang GJ, Shelton A, Welton ML. Epidemilogic and natural history of anal HPV infection and ASIL and cancer in the general population. Semin Colon Rectal Surg 2004; 15:210-214.
5. Safavi A, Gottesman L, Dailey TH. Anorectal surgery in the HIV+ patient: Update. Dis Colon Rectum 1991; 34:299-304.
6. Nadal SR, Manzione CR, Galvao WM, et al. Perianal diseases in HIV-positive patients compared with seronegative population. Dis Colon Rectum 1999; 42:649-654.
7. Miles AJ, Mellor CH, Gazzard B, et al. Surgical management of anorectal disease in HIV-positive homosexuals. Br J Surg 1990; 77:869-871.
8. Denis BJ, May T, Bigard MA, et al. Lesions anales et peri-anales au cours des infections symptomatiques par le VIH. Etude prospective d'une serie de 190 patients. Gastroenterol Clin Biol 1992; 16:148-154.
9. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004; 15:357-364.
10. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2-S7.
11. Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997; 102:9-15.
12. Arican O, Guneri F, Bilgic K, et al. Topical imiquimod 5% cream in external anogenital warts: A randomized, double-blind, placebo-controlled study. J Dermatol 2004; 31:627-631.
13. Gross G. Polyphenon E. A new topical therapy for condylomata acuminata. Hautarzt 2008; 59:31-35.
14. Stockfleth E, Beti H, Orasan R, et al. Topical Polyphenon E in the treatment of external genital and perianal warts: A randomized controlled trial. Br J Dermatol 2008; 158:1329-1338.
15. Badawi A, Shokeir HA, Salem AM, et al. Treatment of genital warts in males by pulsed dye laser. J Cosmet Laser Ther 2006; 8:92-95.
16. Gollock JM, Slatford K, Hunter JM. Scissor excision of anogenital warts. Br J Vener Dis 1982; 58:400-401.
17. Jensen SL. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata. Lancet 1985; 2:1146-1148.
18. Alam M, Stiller M. Direct medical costs for surgical and medical treatment of condylomata acuminata. Arch Dermatol 2001; 137: 337-341.
19. Beck DE, Jaso RG, Zajac RA. Surgical management of anal condylomata in the HIV-positive patient. Dis Colon Rectum 1990; 33:180-183.
20. de la Fuente SG, Ludwig KA, Mantyh CR. Preoperative immune status determines anal condyloma recurrence after surgical excision. Dis Colon Rectum 2003; 46:367-373.
21. Manzione CR, Nadal SR, Calore EE. Postoperative follow-up of anal condylomata acuminata in HIV-positive patients. Dis Colon Rectum 2003; 46:1358-1365.
22. De Panfilis G, Melzani G, Mori G, et al. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Transm Dis 2002; 29:121-125.
23. Weiss EG, Wexner SD. Surgery for anal lesions in HIV-infected patients. Ann Med 1995; 27:467-475.
24. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 3:357-361.
25. Gyllensten UB, Erlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci 1988; 85:7652-7656.
26. Kaufhold A, Podbielski A, Baumgarten G, et al. Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Micro-biol Lett 1994; 119:19-25. (Pubitemid 124012158)
27. Quint WG, Pagliusi SR, Lelie N, et al. Results of the first world health organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 2006; 44:571-579.
28. Hope AC. A simplified Monte Carlo significance test procedure. J R Stat Soc Series B. 1968; 30:582-598.
29. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat 1996; 5:299-314.
30. Nathan M, Hickey N, Mayuranathan L, et al. Treatment of anal human papillomavirus-associated disease: A long term outcome study. Int J STD AIDS 2008; 19:445-449.
31. Dupin N. Genital warts. Clin Dermatol 2004; 22:481-486.
32. Kreuter A, Brockmeyer NH, Weissenborn SJ, et al. 5% imi-quimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata. Arch Dermatol 2006; 142: 243-244.
33. Venturoli S, Ambretti S, Cricca M, et al. Correlation of high-risk human papillomavirus genotypes persistance and risk of residual or recurrent cervical disease after surgical treatment. J Med Virol 2008; 80:1434-1440.
34. Che YM, Wang JB, Liu YH. Correlation between deoxyribonu-cleic acid loads of human papillomavirus and recurrence of con-dylomata acuminata. Int J STD AIDS 2005; 16:605-607.
35. Stevens AJ, Drenon EA, Katz JA, et al. Condyloma severity scoring system predicts recurrence. Dis Colon Rectum 2004; 47:616-617(P26).
36. Sanclemente G, Herrera S, Tyring SK, et al. Human papilloma virus (HPV viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. J Eur Dermatol Venerol 2007; 21:1054-1060.